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Abstract: Anew procedure for the aggregation of human albumin and 99mTc-labelling of the
prepared macroaggregated albumin are presented. Simple methods for quantifying of all the
radiochemical impurities existing in 99mTc-MAA were tested. Thus, 85 % methanol was
used as the mobile phase in paper and ITL chromatography with Whatman No 1 and
ITLC-SA strips. A system of two solvents (acetone and 1 M NaCl or 0.9 % NaCl) was used
for 3 MM paper, ITLC-SA and ITLC-SG strips and silica gel plates as the stationary phase.
Low-voltage paper electrophoresis with Whatman 3 MM paper sheets soaked in barbiturate
buffer and the gel chromatography column method (Sephadex G-25) were also applied. Fil-
tration through syringe filters, proposed by European and Yugoslav Pharmacopoeia, was
performed for comparison. The application of the mentioned tests lead to consistent results
for the labelling efficiency (> 98.5 %) and percent radiochemical impurities of 99mTc-MAA.
Determination of the particles number in a counter chamber and their size distribution under
a light microscope with a calibrated ocular scale gave the result of 300000 –350000 particles
per 1 mg of HA. This confirmed that the human albumin macroaggregates prepared by our
new procedure is remarkably improved and convenient for routine diagnostic purposes.
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INTRODUCTION
Many radiopharmaceuticals are currently used for various nuclear medicine tests.
Since they are administered to humans, they should satisfy the same important criteria as
conventional drugs, namely they should be sterile and pyrogen free and they should un-
dergo all quality control measurements required of conventional drugs.1–3 Some of
radiopharmaceuticals meet most of the requirements for their use, while others warrant fur-
ther development or replacement.
Human albumin macroaggregates (MAA) labelled with 99mTc is a radiopharma-
ceutical widely used for the diagnosis of lung diseases and radionuclide venography.4 The
addition of 99mTc-pertechnetate (99mTcO4–) obtained from 99Mo-99mTc radionuclide gen-
erator enables the simple preparation of 99mTc-MAA.
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Human albumin macroaggregates were prepared in kit form for the first time around
1970.5,6 Nowthis radiopharmaceuticalusuallycontainsa lyophilizedpreparationofaggregated
human albumin, stannous chloride and other substances as preservatives or stabilizers, depen-
ding on the manufacturer. The particle size ranges from 10 m to 100 m, which must be
checked prior to the administration to humans. The widespread use of 99mTc-MAA in every-
day diagnostic practice in nuclear medicine necessitated the development of simple, rapid and
economic methods of its quality control.7–11
In the Laboratory for Radioisotopes, The Institute of Nuclear Sciences "Vin~a", MAA
has been prepared since 1978.12 The procedure for preparation was further developed and
changed but the results of MAA quality control suggested some non-uniformity in their
quality. This paper presents a new procedure obtained as the result of investigations to opti-
mize the aggregation conditions (pH, concentrations of human albumin and tin (II), tem-
perature of aggregation and stirring rate). Now this radiopharmaceutical has the most fa-
vourable composition of a lyophilized preparation with glycine as a new stabilizer. The
standard procedure for the determination of the number of lymphocytes was used for the
determination of particles number of 99mTc-labelled MAA.13 Besides the quality control
methods proposed in USP (XXIII),14 European pharmacopoeia (1997)15 and Pharmaco-
poeia Yugoslavica (2000),16 we assayed using more detailed radiochromatographic meth-
ods for the determination of labelling efficiency and radiochemical purity of 99mTc-MAA.
For this purpose, the current radiochromatographic and electrophoresis methods for the de-
tection of all impurities in 99mTc-labelled radiopharmaceuticals were evaluated. In this
way, rapid and simple methods for the determination of the labelling efficiency and
radiochemical purity were established.
EXPERIMENTAL
Preparation of human albumin macroaggregates
Aggregation of human albumin (20 % HA, National Blood Transfusion Institute, Belgrade) was per-
formed in a double walled glass vessel, at a constant temperature (343  1) K, maintained by circulating
thermostated water (thermostat model VEB MLW Prufgerate-Werk, Medingen, Germany). The mixture of
HA in acetate buffer (pH 5) was stirred at 350 rpm for 30 min. Subsequently, SnCl2  2H2O (Merck, p. a.) in
0.1 M HCl was added and the stirring was continued for a further 15 min. After cooling, the supernatant was
decanted and the human albumin macroaggregates were rinsed three times with acetate buffer. The aggre-
gates were separated by centrifugation (5 min at 2000 g). The prepared suspension was diluted with acetate
buffer and glycine (Merck, p.a.) was added. The suspension after partitioning through 18-gauge needles was
lyophilised. The complete operation was carried out in a laminar airflow hood and under aseptic conditions.
The used equipment had been previously sterilized, and all necessary solutions were sterilized by membrane
filtration using 0.20 m cellulose acetate dispensable syringe filters (Millipore Corporation, USA). The ob-
tained MAA in kit form was a sterile, pyrogen-free preparation with 8.8 mg macroaggregates per vial (7 mg
HA before aggregation), 0.275 mg SnCl2  2H2O and 2.5 mg glycine per vial. The
99mTc-labelling of MAA
was carried out by adding 99mTcO4
- from a 99Mo-99mTc radionuclide generator (Laboratory for Radioiso-
topes, INS "Vin~a"), to the vial and shaking vigorously for a few minutes.
Radiochemical purity
For the measurements of the labelling efficiency of 99mTc-MAA, instant thin-layer chromatography
(ITLC) combined with paper chromatography, paper low-voltage electrophoresis and gel filtration were ap-
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plied. In these methods small aliquots of the radiopharmaceutical preparation (37 kBq) were spotted on a pa-
per strip (Whatman), ITLC-SA or ITLC-SG strips (Gelman Instrument Company, Ann Arbor, Michigan,
USA) made of glass fiber impregnated with polysilicic acid or silica gel, respectively, as well as TLC-plates
covered with silica gel. Paper chromatography was performed using Whatman No 1 (2  16 cm) with 85 %
(w/v) methanol (Merck, p.a.) and Whatman 3 MM (2  16 cm) with two solvents: acetone (Merck, p.a.) and 1
M NaCl, (Merck, p.a.). The ITLC-SA or ITLC-SG strips (2  16 cm), as well as the TLC-plates (2  16 cm)
were developed first in acetone till 15 cm and after air drying in 0.9 % (w/v) NaCl or 1 M NaCl till 7 cm. One
centimeter cuts were counted in a gamma-scintillation counter and the labelling efficiency of 99mTc-MAA
was determined.
Low-voltage paper electrophoresis (220 V, 2 h) was performed applying a radioactive sample ( 37
kBq) on Whatman 3 MM paper sheets soaked in barbiturate buffer, pH 8.6. After electrophoresis, the distribu-
tion of the activity along the paper strips was determined by measuring 1-cm dried pieces in a gamma-sci-
ntillation counter. The percentage of radioactivity of each fraction was determined from its ratio to the total ra-
dioactivity of the strip.
Gel filtration was performed by passing a 0.1-ml aliquot ( 37 kBq) of 99mTc-MAAthrough a Sephadex
G-25 column (Pharmacy fine, Upsala, Sweden) with 0.9 % (w/v) NaCl as the eluting solvent. Since it was not
possible to scan the column, it was eluted with 35 ml of 0.9 % (w/v) NaCl. One-millilitre aliquots were col-
lected in vials and the radioactivity of each aliquot was measured in a gamma counter.
Pharmacopoeia Yugoslavica 2000 (Ph. Yug. V) proposes the determination of non-filterable radioactiv-
ity using dispensable syringe filters. In our examination, 0.3-ml aliquots ( 37 kBq) of 99mTc-MAA were
passed through cellulose acetate dispensable syringe filters with 0.20 m and 0.45 m pore size poly-
ethersulfone membrane filters (Whatman), followed by washing with 20 ml 0.9 % (w/v) NaCl.
Particle counting and size measurements
The number of particles was determined in a counter chamber under a Zeiss Standard GFLmicroscope.
A 0.1 ml aliquot of human albumin macroaggregates coloured with 0.1 % Rose Bengal solution was intro-
duced into the counter chamber, the particles were allowed to settle for 1 min and then observed under the mi-
croscope. Their size distribution was checked under a microscope with a calibrated ocular scale.
RESULTS AND DISCUSSCION
Radiochemical purity
The radiochemical purity of a radiopharmaceutical is the fraction of the total radioactiv-
ity in the desired form. Several radiochemical impurities can exist in 99mTc-MAA prepara-
tions, such as a colloid reduced and hydrolysed fraction (99mTc-Sn colloid), free per-
technetate (99mTcO4–) and a soluble 99mTc-albumin (99mTc-HA).10 Each of these compo-
nents are characterized by Rf value, which is defined as the ratio of the distance the compo-
nent had traveled to the distance the solvent front had advanced from the original point of ap-
plication of the investigated compound. As no single ideal method exists to determine all the
mentioned radiochemical impurities during the same experiment, different stationary and
mobile phases were combined. The radiochromatographic results are presented in Tables I
and II. The results are expressed as mean values of at least six tests with the standard devia-
tions also given. The yields (%) represent the amounts of the mentioned radiochemical impu-
rities and hence the labelling yields of 99mTc-MAA. The obtained chromatographic results
confirmed that most of the 99mTc activity remained at the application spot on the paper, ITLC
strips or silica gel plates. Technetium-99m pertechnetate is the only radiochemical impurity
determined by the paper and ITL chromatographic methods in 85 % methanol.
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TABLE I. Radioanalytical paper and ITL chromatography of 99mTc-MAA with 85 % methanol
Solid phase Yield (%) Rf = 0.0 Yield (%) Rf = 0.36 – 0.45 Yield (%) Rf = 0.73 – 0.85
Whatman No 1 80.1  2.2 19.9  2.2 –
ITLC-SG 91.7  2.4 – 8.3  2.4
TABLE II. Radioanalytical paper and ITL chromatography of 99mTc-MAAwith acetone and 1 M NaCl (*0.9
% NaCl)
Solid phase Yield (%) Rf = 0.0 Yield (%) Rf = 0.4 – 0.5 Yield (%) Rf = 0.9 – 1.0
Whatman 3 MM 98.4  0.4 1.5  0.3 0.1  0.1
ITLC-SA* 98.8  0.2 0.8  0.1 0.4  0.1
ITLC-SG 98.7  0.1 0.7  0.1 0.7  0.1
ITLC-silica gel 99.7  0.1 0.2  0.1 0.2  0.1
The results of the paper electrophoresis are presented at Fig. 1. Low-voltage electro-
phoresis in barbiturate buffer is a convenient method for the determination of the labelling
efficiency and radiochemical purity of 99mTc-MAA. Human albumin macroaggregates la-
belled with technetium-99m remained at the origin; non-aggregated 99mTc-HA migrated
(6 – 7 cm), as well as free TcO4– (12 – 13 cm) in the anodic direction. The percentage of ra-
dioactivity of each fraction was determined from their ratio to the total radioactivity of the
strip. The investigations of 27 different batches of human albumin macroaggregates la-
belled with technetium-99m showed that 99mTc-MAA was a radiopharmaceutical of high
radiochemical purity (99.7  0.4 %). The results of radiochemical purity studies with gel
filtration confirmed that the maximum of 99mTc activity was retained at the top of the col-
umn. The percentages of filtrated radioactive impurities were determined by equation:
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Fig. 1. Distribution of radioactivity of 99mTc-MAA along the electropherogram (barbiturate buffer pH = 8.6,
220 V, 2 h)
% radiochemical impurities =
filtrate radioactivity(cpm)
(gross syringe, cpm) (re sidual syringe, cpm)
 100
where cpm is counts per minute. These experiments showed that 98.5  0.9 % of the total
radioactivity results from 99mTc-labelled MAA and 1.5  0.2 % is related to a colloid re-
duced and hydrolysed fraction (  	 99mTc-Sn colloid, free pertechnetate (  	
99mTcO4–) and soluble 99mTc-albumin ( 
 	 99mTc-HA)).
The results of the investigation of non-filterable radioactivity are presented in Table III
as mean values of six experiments for each syringe filter together with standard deviations.
As it can be seen the results of both series of experiments are very similar and are in good
agreement with the values proposed by Ph. Yug. V (> 90 %).
TABLE III. Radiochemical purity determination of 99mTc-MAA by filtration
The type of syringe filter
Membrane bound
99mTc-MAA (%)
Radiochemical impurities in
filtrate (%)
0.20 m cellulose acetate membrane filter 99.3  0.4 0.7  0.4
0.45 m polyethersulfone membrane filter 99.4  0.1 0.6  0.1
The literature data, as well as our previous experience dealing with human albumin
macroaggregates labeled with 99mTc, show that a great percentage of the labelled particles
adhered to the plastic syringes. Therefore, the used aliquots of the preparation were mea-
sured prior and after being spotted on strips, columns or syringe filters. These results
showed that 14.8  3.0 % of radioactivity adhered to the used syringe (1-ml tip syringe,
Zdravlje, Leskovac, Yugoslavia).
The number of particles and their size distribution were determined in human albumin
macroaggregates in 16 squares of the counter chamber. The average number of particles
per preparation unit (5 ml, 7 mg HA) was estimated to 2160000 – 2450000 that is 300000
– 350000 particles per 1 mg of HA. More than 80 % of the particles were in the size range
from 40 – 60 m, less than 1 % were greater than 100 m and no particles greater than 150
m were founded.
CONCLUSION
The results obtained by different techniques show that the used chromatographic,
electrophoresis and gel filtration methods are appropriate for routine quality control of
99mTc-MAA. They allow the determination of all three radiochemical impurities in this
radiopharmaceutical. Only the results of paper chromatography and ITLC-SG in 85 %
methanol were not in accordance with the results obtained by the other methods. The sta-
tionary phase (paper and ITL chromatography on SAor SG strips and silica gel plates) did
not affect the reproducibility of the separation of the investigated radiochemical impurities
by the two solvents. These results are in good accordance with electrophoresis, gel chro-
matography as well as syringe filterability results with values 98.5 % – 99.7 % of total ra-
dioactivity assignable to 99mTc-MAA. Moreover, ITL-chromatography with acetone and
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0.9 % NaCl or 1 M NaCl is a simple and quick method appropriate for routine quality con-
trol of 99mTc-MAA. This confirmed that human albumin macroaggregates prepared by
the new procedure and labelled with 99mTc are a radiopharmaceutical of high labelling ef-
ficiency and radiochemical purity, with a satisfactory number of particles of the required
size. In this way the MAA prepared in the Laboratory for Radioisotopes are remarkably
improved. Their correct qualities enable good results in routine application in diagnostic or
nuclear medicine to be attained.
IZVOD
ODRE\IVAWERADIOHEMIJSKE^ISTO]EIBROJA^ESTICAKOD
MODIFIKOVANOG 99mTc-MAKROAGREGATAALBUMINA
DIVNA\OKI], DRINA JANKOVI]iTATJANAMAKSIN
Laboratorija za radioizotope, Institut za nuklearne nauke "Vin~a", p. pr. 522, 11001 Beograd, E-mail:
djokici@vin.bg.ac.yu
U radu je prikazan novi postupak agregacije qudskog albumina i obele`avawe do-
bijenih makroagregata albumina tehnecijumom-99m. U ciqu odre|ivawa prisutnih radio-
hemijskih ne~isto}a dobijenog 99mTc-MAA primewuju se jednostavne radiohemijske metode.
Tako se 85 % metanol koristi kao mobilna faza pri papirnoj (Whatman No 1) i hroma-
tografiji na tankom sloju (ITLC-SA). Pri upotrebi 3MM papira, ITLC-SA, ITLC-SG traka i
silika-gel plo~a kao mobilna faza koristi se sistem od dva rastvara~a: aceton i 1 M NaCl
ili 0.9 % NaCl. U radu su tako|e kori{}ene niskonaponska elektroforeza sa trakama
Whatman 3 MM papira pokva{enim u barbituratnom puferu, kao i gel-hromatografija na
koloni (Sephadex G-25). U ciqu pore|ewa dobijenih rezultata kori{}ena je i metoda
filtracije kroz odgovaraju}e filtre, kako je propisano Evropskom i Jugoslovenskom far-
makopejom. Rezultati dobijeni za prinos obele`avawa i sadr`aj svih prisutnih radio-
hemijskih ne~isto}a primenom navedenih metoda su u saglasnosti sa propisanim. Odre|i-
vawe broja dobijenih ~estica i wihove raspodele po veli~ini je pokazalo da se od 1 mg
qudskog albumina kori{}enog za agregaciju dobija 300000 – 350000 ~estica. Ovi rezultati
potvr|uju da je kvalitet makroagregata qudskog albumina pripremqenih novim postupkom
znatno poboq{an. Nakon obele`avawa tehnecijumom-99m dobijen je radiofarmaceutik
visoke radiohemijske ~isto}e (> 98,5 %), propisanog broja ~estica sa odgovaraju}om raspo-
delom po veli~ini, te on u potpunosti ispuwava sve uslove za rutinsku primenu u dijagno-
sti~ke svrhe.
(Primqeno 8. marta 2002)
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